user

How to Treat EGFR-Mutated Non-Small Cell Lung Cancer

被引：4
|
作者：
Belani, Neel [1 ,4 ]
Liang, Katherine [2 ]
Fradley, Michael [3 ]
Judd, Julia [1 ]
Borghaei, Hossein [1 ]
机构：
[1] Fox Chase Canc Ctr, Dept Hematol & Oncol, Philadelphia, PA USA
[2] Temple Univ Hlth Syst, Dept Internal Med, Philadelphia, PA USA
[3] Univ Penn, Perelman Sch Med, Cardiooncol Translat Ctr Excellence, Div Cardiol, Philadelphia, PA 19104 USA
[4] Univ Penn, Perelman Sch Med, 333 Cotman Ave, Philadelphia, PA 19111 USA
来源：
JACC: CARDIOONCOLOGY | 2023年 / 5卷 / 04期
关键词：
cardiomyopathy; lung cancer; tyrosine kinase inhibitor; OSIMERTINIB;
D O I：
10.1016/j.jaccao.2023.04.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：542 / 545
页数：4
相关论文
共 50 条
  • [1] Treatment strategy of EGFR-mutated non-small cell lung cancer
    Tanaka, Fumihiro
    Yoneda, Kazue
    Takenaka, Masaru
    Kuroda, Koji
    [J]. JOURNAL OF THORACIC DISEASE, 2022, 14 (03) : 602 - 606
  • [2] Emerging drugs for EGFR-mutated non-small cell lung cancer
    Sukrithan, Vineeth
    Deng, Lei
    Barbar, Alexander
    Cheng, Haiying
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2019, 24 (01) : 5 - 16
  • [3] Systemic treatment of EGFR-mutated non-small cell lung cancer
    Czyzykowski, Rafal L.
    Wrona, Ewa K.
    Talajko, Agata
    Hasinska, Aleksandra M.
    Potemski, Piotr J.
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2024,
  • [4] Safety of osimertinib in EGFR-mutated non-small cell lung cancer
    Mezquita, Laura
    Varga, Andreea
    Planchard, David
    [J]. EXPERT OPINION ON DRUG SAFETY, 2018, 17 (12) : 1239 - 1248
  • [5] Role of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer
    Rao, Ding-Yu
    Huang, De-Fa
    Si, Mao-Yan
    Lu, Hua
    Tang, Zhi-Xian
    Zhang, Zu-Xiong
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [6] Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung Cancer
    Mambetsariev, Isa
    Arvanitis, Leonidas
    Fricke, Jeremy
    Pharaon, Rebecca
    Baroz, Angel R.
    Afkhami, Michelle
    Koczywas, Marianna
    Massarelli, Erminia
    Salgia, Ravi
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (05)
  • [7] Leptomeningeal carcinomatosis from EGFR-mutated non-small cell lung cancer
    Iuchi, T.
    Shingyoji, M.
    Setoguchi, T.
    Yoshida, Y.
    Ashinuma, H.
    Hasegawa, Y.
    Sakaida, T.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [8] Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
    Alessandro Leonetti
    Sugandhi Sharma
    Roberta Minari
    Paola Perego
    Elisa Giovannetti
    Marcello Tiseo
    [J]. British Journal of Cancer, 2019, 121 : 725 - 737
  • [9] Managing Acquired Resistance in EGFR-Mutated Non-Small Cell Lung Cancer
    Forde, Patrick M.
    Ettinger, David S.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (08) : 528 - 532
  • [10] Optimizing adjuvant therapy in EGFR-mutated non-small cell lung cancer
    Shepherd, Annemarie F.
    Preeshagul, Isabel R.
    Shaverdian, Narek
    Wu, Abraham J.
    Gelblum, Daphna Y.
    Gomez, Daniel R.
    Rimner, Andreas
    Simone, Charles B., II
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (23)
12345